A Potential of sFasL in Preventing Gland Injury in Sjogren’s Syndrome

Figure 1

Reduced expression of sFasL in SS patient. The serum levels of sFasL in SS patients () and healthy controls (HC) () were detected by Luminex assay. Each symbol represented an individual sample and horizontal lines showed median values. Mann–Whitney test was conducted to compare the data between two groups. was considered as statistic significance.